Literature DB >> 16150110

Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment.

Eloisa Gitto1, Russel J Reiter, Giuseppe Sabatino, Giuseppe Buonocore, Carmelo Romeo, Placido Gitto, Concetta Buggé, Giuseppe Trimarchi, Ignazio Barberi.   

Abstract

Improved survival because of advances in neonatal care has resulted in an increased number of infants at risk for chronic lung disease. Even though the etiology of lung injury is multifactorial, recent animal and clinical data indicate that pulmonary damage depends in large part on the ventilatory strategies used. Ventilator-associated lung injury was believed to result from the use of high pressure, thus, the term barotraumas. This trauma is believed to involve free-radical damage. Oxidant injury is a serious cause of lung injury. In the present study, 110 newborns with respiratory distress syndrome were studied; 55 were treated with melatonin and the other 55 with placebo. All the subjects were mechanically ventilated with or without guaranteed volume. Proinflammatory cytokines [interleukin (IL)-6, IL-8 and tumor necrosis factor (TNF)-alpha] were measured in tracheobronchial aspirate and the clinical outcome was evaluated. Melatonin treatment reduced the proinflammatory cytokines and improved the clinical outcome. The beneficial action of melatonin presumably related to its antioxidative actions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16150110     DOI: 10.1111/j.1600-079X.2005.00251.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  29 in total

1.  Pharmacokinetics of melatonin in preterm infants.

Authors:  Nazakat M Merchant; Denis V Azzopardi; Ahmed F Hawwa; James C McElnay; Benita Middleton; J Arendt; Tomoki Arichi; Pierre Gressens; A David Edwards
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

2.  Elevated blood levels of inflammation-related proteins are associated with an attention problem at age 24 mo in extremely preterm infants.

Authors:  T Michael O'Shea; Robert M Joseph; Karl C K Kuban; Elizabeth N Allred; Janice Ware; Taryn Coster; Raina N Fichorova; Olaf Dammann; Alan Leviton
Journal:  Pediatr Res       Date:  2014-04-10       Impact factor: 3.756

3.  The role of plasminogen activator inhibitor-1 and angiotensin-converting enzyme gene polymorphisms in bronchopulmonary dysplasia.

Authors:  Deniz Anuk Ince; Fatma Belgin Atac; Servet Ozkiraz; Ugur Dilmen; Hande Gulcan; Aylin Tarcan; Namik Ozbek
Journal:  Genet Test Mol Biomarkers       Date:  2010-09-06

Review 4.  The Safety of Melatonin in Humans.

Authors:  Lars Peter Holst Andersen; Ismail Gögenur; Jacob Rosenberg; Russel J Reiter
Journal:  Clin Drug Investig       Date:  2016-03       Impact factor: 2.859

Review 5.  Neuroprotection Strategies for Term Encephalopathy.

Authors:  Fernando F Gonzalez
Journal:  Semin Pediatr Neurol       Date:  2019-08-07       Impact factor: 1.636

Review 6.  Bench to cribside: the path for developing a neuroprotectant.

Authors:  Nelina Ramanantsoa; Bobbi Fleiss; Myriam Bouslama; Boris Matrot; Leslie Schwendimann; Charles Cohen-Salmon; Pierre Gressens; Jorge Gallego
Journal:  Transl Stroke Res       Date:  2012-12-21       Impact factor: 6.829

Review 7.  Neuroendocrine-immune correlates of circadian physiology: studies in experimental models of arthritis, ethanol feeding, aging, social isolation, and calorie restriction.

Authors:  Ana I Esquifino; Pilar Cano; Vanesa Jiménez-Ortega; Pilar Fernández-Mateos; Daniel P Cardinali
Journal:  Endocrine       Date:  2007-09-29       Impact factor: 3.633

Review 8.  Neuroprotection in the newborn infant.

Authors:  Fernando F Gonzalez; Donna M Ferriero
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

9.  Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia.

Authors:  Li Pan; Jian-Hua Fu; Xin-Dong Xue; Wei Xu; Ping Zhou; Bing Wei
Journal:  World J Pediatr       Date:  2009-08-20       Impact factor: 2.764

Review 10.  Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review.

Authors:  Sreedevi Koppisetti; Bharat Jenigiri; M Pilar Terron; Sandra Tengattini; Hiroshi Tamura; Luis J Flores; Dun-Xian Tan; Russel J Reiter
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.